Genus plc (GNS.L)

GBp 1618.0

(-1.46%)

Market Cap (In GBp)

1.06 Billion

Revenue (In GBp)

668.8 Million

Net Income (In GBp)

7.9 Million

Avg. Volume

139.85 Thousand

Currency
GBp
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1478.0-2378.0
PE
-269.67
EPS
-0.06
Beta Value
0.343
ISIN
GB0002074580
CUSIP
G3827X105
CIK
-
Shares
65691782.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Jorgen Kokke
Employee Count
-
Website
https://www.genusplc.com
Ipo Date
2000-07-06
Details
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in reproductive, and other technical services to farmers. Genus plc has a strategic collaboration with Beijing Capital Agribusiness Co. Ltd to pursue the porcine reproductive respiratory syndrome virus resistant regulatory and development work in China. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.